Open AccessTreatment approaches for managing patients with hematological malignancies in the time of COVID-19 pandemic
Author(s) -
Güldane Cengiz Seval,
Pervin Topçuoğlu,
Taner Demirer
Publication year - 2021
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-2101-276
Subject(s) - medicine , pandemic , immunosuppression , covid-19 , intensive care medicine , transmission (telecommunications) , health care , disease , hematological disorders , healthcare system , infectious disease (medical specialty) , immunology , virology , economic growth , economics , engineering , electrical engineering , outbreak
The COVID-19 pandemic is a unique challenge to the care of patients with hematological malignancies. We aim to provide supportive guidance to clinicians making individual patients decisions during the COVID-19 pandemic, in particular during periods that access to healthcare resources may be limited.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom